Review article

Systemic therapy of metastatic breast cancer

Robert Šeparović orcid.org/0000-0002-4002-2699 ; Department of Medical Oncology; University Hospital for Tumors; Sestre milosrdnice University Hospital Center; Zagreb; Croatia
Robert Zorica ; Department of Medical Oncology; University Hospital for Tumors; Sestre milosrdnice University Hospital Center; Zagreb; Croatia
Tajana Silovski orcid.org/0000-0002-4699-5432 ; Department of Medical Oncology; University Hospital for Tumors; Sestre milosrdnice University Hospital Center; Zagreb; Croatia
Mirjana Pavlović orcid.org/0000-0002-9633-064X ; Department of Medical Oncology; University Hospital for Tumors; Sestre milosrdnice University Hospital Center; Zagreb; Croatia
Ljubica Vazdar ; Department of Medical Oncology; University Hospital for Tumors; Sestre milosrdnice University Hospital Center; Zagreb; Croatia
Vesna Pavlica ; Hospital Pharmacy; University Hospital for Tumors; Sestre milosrdnice University Hospital Center; Zagreb; Croatia

Abstract

Systemic therapy of metastatic breast cancer is not curative and its goal is life prolongation and improvement of quality of life. Treatment of metastatic breast cancer usually involvesendocrine therapy and/or chemotherapy with or without targeted therapy. The use of the minimally toxic endocrine therapies is preff ered to the use of cytotoxic therapy whenever reasonable.

Keywords

breast cancer; hormone therapy; cytotoxic agents; biological therapy; bisphosphonates

Hrčak ID:

199079

URI

https://hrcak.srce.hr/199079

Publication date:

29.12.2014.

Article data in other languages: croatian

Visits: 1.750 *